Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunophenotyping of Patients With MPS II Treated With Enzyme Replacement Therapy

NCT04976231 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04976231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunophenotyping of Patients With MPS II Treated With Enzyme Replacement Therapy
Lead sponsor
Duke University
Phase
Observational
Overall status
Terminated
Start date
April 1, 2022
Completion date
April 26, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hunter syndrome, mps ii, mucopolysaccharidosis ii